An Important History Lesson for Gene-Editing Investors
https://www.fool.com/investing/2023/12/02/an-important-history-lesson-for-gene-editing-inves/?source=iedfolrf0000001
Dec 02, 2023 - Gene editing holds tremendous promise for patients and investors alike. But the road to success won't be easy.
0
The Market's Up This Year. Do You Feel Like You Are Winning?
https://www.fool.com/investing/2023/12/04/the-markets-up-this-year-do-you-feel-like-you-are/?source=iedfolrf0000001
Dec 04, 2023 - We've also got a look at two stocks worth watching and the popular toys for this holiday season.
0
6 Words That Explain Why CRISPR Stock Isn't Soaring Despite the Recent FDA Approval for Its Gene-Editing Therapy
https://www.fool.com/investing/2023/12/21/6-words-that-explain-why-crispr-stock-isnt-soaring/?source=iedfolrf0000001
Dec 21, 2023 - Should you buy CRISPR's stock on the dip?
0
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year
https://www.fool.com/investing/2024/01/15/heres-why-crispr-therapeutics-stock-rose-54-last-y/?source=iedfolrf0000001
Jan 15, 2024 - Key regulatory developments sent this biotech stock higher.
0
Got $100? 2 Top Cathie Wood Stocks to Buy and Hold.
https://www.fool.com/investing/2024/02/04/got-100-2-top-cathie-wood-stocks-to-buy-and-hold/?source=iedfolrf0000001
Feb 04, 2024 - These stocks are steals right now.
0
Is It Too Late to Buy CRISPR Therapeutics Stock?
https://www.fool.com/investing/2024/03/16/is-it-too-late-to-buy-crispr-therapeutics-stock/?source=iedfolrf0000001
Mar 16, 2024 - The biotech has been making a lot of noise since late last year.
0
Is This News a Setback or a Step Forward for CRISPR Therapeutics?
https://www.fool.com/investing/2023/12/06/is-this-setback-or-step-forward-for-crispr/?source=iedfolrf0000001
Dec 06, 2023 - It's important to look at the news through a long-term lens.
0
1 Biotech Stock That Could Be the Next Amgen
https://www.fool.com/investing/2023/12/13/1-biotech-stock-that-could-be-the-next-amgen/?source=iedfolrf0000001
Dec 13, 2023 - The emergence of genomic medicine as a viable modality could transform this midcap biotech into the next Amgen.
0
3 Money-Saving Tricks for Investing in Biotech Stocks in 2024
https://www.fool.com/investing/2023/12/22/3-money-saving-tricks-for-investing-in-biotech/?source=iedfolrf0000001
Dec 22, 2023 - Doing a little math and doing a little extra research can make a big difference.
0
1 Green Flag and 1 Red Flag for Bluebird Bio Stock
https://www.fool.com/investing/2023/12/23/1-green-flag-and-1-red-flag-for-bluebird-bio-stock/?source=iedfolrf0000001
Dec 23, 2023 - The stock has been in the news lately.
0
Page 1>